SCM Lifescience Co., Ltd.

A298060

KR7298060005

Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 03:30:00 28/05/2024 am IST			5-day change	1st Jan Change
2,905 ^KRW	-0.68%		-5.07%	-23.15%

2023	SCM Lifescience Co., Ltd.(KOSDAQ:A298060) dropped from S&P Global BMI Index	CI
2023	SCM LifeScience to Raise 30.9 Billion Won via Share Issuance	MT

SCM Lifescience Co., Ltd.(KOSDAQ:A298060) added to S&P Global BMI Index

December 21, 2020 at 10:30 am IST

Latest news about SCM Lifescience Co., Ltd.

SCM Lifescience Co., Ltd.(KOSDAQ:A298060) dropped from S&P Global BMI Index	18/23/18	CI
SCM LifeScience to Raise 30.9 Billion Won via Share Issuance	12/23/12	MT
Scm Lifescience Co., Ltd. Appoints Song Sun-Uk as CEO	15/21/15	CI
Vita Therapeutics, Inc. announced that it has received $32 million in funding from Cambrian BioPharma, Inc., SCM Lifescience Co., Ltd., Early Light Ventures	23/21/23	CI
Vita Therapeutics, Inc. announced that it expects to receive $22.443036 million in funding	12/21/12	CI
SCM Lifescience Co., Ltd.(KOSDAQ:A298060) added to S&P Global BMI Index	21/20/21	CI
SCM Lifescience Co., Ltd. has completed an IPO in the amount of KRW 30.6 billion.	11/20/11	CI
SCM Lifescience Co., Ltd. has filed an IPO.	13/19/13	CI
Genexine Inc. and SCM Lifescience Co. completed the acquisition of substantially all of the assets of Argos Therapeutics Inc.	13/19/13	CI
Genexine Inc. and SCM Lifescience Co. entered into an asset purchase agreement to acquire substantially all of the assets of Argos Therapeutics Inc. for $11.3 million.	22/19/22	CI
SCM LIFESCIENCE Co., Ltd. announced that it has received KRW 5.5000032 billion in funding from Duopharma Biotech Berhad	31/18/31	CI
SCM LIFESCIENCE Co., Ltd. announced that it expects to receive KRW 5.5000032 billion in funding from CCM Duopharma Biotech Berhad	25/18/25	CI

Chart SCM Lifescience Co., Ltd.

Duration

Period

More charts

SCM Lifescience Co Ltd is a Korea-based company engaged in the research and development of medicines. The Company is engaged in the business of the development and production of cell therapy products, the agency testing of cell production and quality, adult stem cell consulting, cosmetics manufacturing, and hair growth protein manufacturing.

Sector

Biotechnology & Medical Research

Calendar

09/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Bio Therapeutic Drugs

	1st Jan change	Capi.
SCM LIFESCIENCE CO., LTD.	-23.15%	44M
VERTEX PHARMACEUTICALS INCORPORATED	+9.82%	118B
REGENERON PHARMACEUTICALS, INC.	+10.40%	106B
BIONTECH SE	-11.15%	23.4B
ARGENX SE	-1.69%	22.1B
GENMAB A/S	-10.23%	18.34B
WUXI APPTEC CO., LTD.	-41.92%	16.59B
BEIGENE, LTD.	-15.52%	15.97B
NEUROCRINE BIOSCIENCES, INC.	+6.93%	14.03B
SAREPTA THERAPEUTICS, INC.	+17.84%	11.67B